Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.

Opioid antagonists attenuate behavioral effects of amphetamine and amphetamine-induced increases in extracellular dopamine levels in nucleus accumbens and striatum of rats but do not alter those effects of cocaine. This study was performed to determine 1) if the effect of opioid antagonists on the dopamine response to amphetamine is mediated in either the terminal or cell body region of the nigrostriatal and mesolimbic pathways, and 2) if the enkephalinase inhibitor thiorphan, which slows degradation of endogenous opioid peptides, increases the dopamine response to amphetamine but not to cocaine. Microdialysis probes were placed either into a dopaminergic terminal region or into both a terminal and cell body region of rats. Naloxone methiodide (1.0 microM), a lipophobic opioid antagonist, was administered into either the terminal or cell body region by reverse dialysis, whereas extracellular dopamine was collected in the terminal region. Increases in extracellular dopamine in nucleus accumbens and striatum caused by amphetamine (0.1-6.4 mg/kg, s.c.) were reduced significantly (28-39%) by naloxone methiodide administered into either substantia nigra or ventral tegmentum but not into terminal regions. Thiorphan (10 microM) administered into substantia nigra increased significantly the dopamine response to amphetamine in the ipsilateral striatum by as much as 42% but did not affect the dopamine response to cocaine (3.0-56 mg/kg, i.p.). These results suggest that amphetamine promotes release of endogenous opioids, which, through actions in the ventral tegmentum and substantia nigra, contribute to amphetamine-induced increases in extracellular dopamine in the nucleus accumbens and striatum.

[1]  B. Westerink,et al.  Brain microdialysis and its application for the study of animal behaviour , 1995, Behavioural Brain Research.

[2]  M. Sar,et al.  A topographic localization of enkephalin on the dopamine neurons of the rat substantia nigra and ventral tegmental area demonstrated by combined histofluorescence-immunocytochemistry , 1980, Brain Research.

[3]  H. Akil,et al.  Endogenous opioids: overview and current issues. , 1998, Drug and alcohol dependence.

[4]  P. Kalivas,et al.  Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  M. Fournié-Zaluski,et al.  Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. , 1993, Pharmacological reviews.

[6]  G. Koob,et al.  Methylnaloxonium diffuses out of the rat brain more slowly than naloxone after direct intracerebral injection , 1991, Neuroscience Letters.

[7]  N. Koshikawa,et al.  Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors , 1999, Neuroscience.

[8]  R. Spanagel,et al.  The Effects of Opioid Peptides on Dopamine Release in the Nucleus Accumbens: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[9]  J. B. Justice,et al.  Differential Effects of δ‐ and μ‐Opioid Receptor Antagonists on the Amphetamine‐Induced Increase in Extracellular Dopamine in Striatum and Nucleus Accumbens , 1996 .

[10]  J. Schwartz,et al.  High-affinity enkephalin-degrading peptidase in brain is increased after morphine , 1978, Nature.

[11]  G. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[12]  F E Bloom,et al.  Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.

[13]  J. Schwartz,et al.  The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice , 1980, Nature.

[14]  N. Mercuri,et al.  Two cell types in rat substantia nigra zona compacta distinguished by membrane properties and the actions of dopamine and opioids , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  J. B. Justice,et al.  Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. , 1995, European journal of pharmacology.

[16]  S. Holtzman,et al.  Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats , 1987, Neuropharmacology.

[17]  G. Koob,et al.  Role of different brain structures in the expression of the physical morphine withdrawal syndrome. , 1992, The Journal of pharmacology and experimental therapeutics.

[18]  S. Holtzman Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat , 1976, Psychopharmacologia.

[19]  G. Di Chiara,et al.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[20]  P. Deviche Affinity of naloxone and its quaternary analogue for avian central δ and μ opioid receptors , 1997, Brain Research.

[21]  H. Akil,et al.  The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores. , 1995, Brain research.

[22]  R. Wise,et al.  Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. , 1993, The Journal of pharmacology and experimental therapeutics.

[23]  L. Parsons,et al.  Serotonin and Dopamine Sensitization in the Nucleus Accumbens, Ventral Tegmental Area, and Dorsal Raphe Nucleus Following Repeated Cocaine Administration , 1993, Journal of neurochemistry.

[24]  S. Holtzman Behavioral effects of separate and combined administration of naloxone and d-amphetamine. , 1974, The Journal of pharmacology and experimental therapeutics.

[25]  P. Molinoff,et al.  The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. , 1977, The Journal of pharmacology and experimental therapeutics.

[26]  J. B. Justice,et al.  Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens , 1992, Pharmacology Biochemistry and Behavior.

[27]  G. Cohen,et al.  Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. , 1975, Biochemical pharmacology.

[28]  J. Schwartz,et al.  Enkephalin receptors on dopaminergic neurones in rat striatum , 1977, Nature.

[29]  N. Maidment,et al.  Presynaptic Versus Postsynaptic Localization of μ and δ Opioid Receptors in Dorsal and Ventral Striatopallidal Pathways , 1997, The Journal of Neuroscience.

[30]  L. Pellegrino,et al.  stereotaxic atlas of the rat brain , 1967 .

[31]  B. Westerink,et al.  The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[32]  H. Fibiger,et al.  In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis , 1990, Synapse.

[33]  H. Akil,et al.  The cloned μ, δ and κ receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores , 1995, Brain Research.

[34]  J. Schwartz,et al.  Localization of opiate receptors in substantia nigra evidence by lesion studies , 1979, Neuroscience Letters.

[35]  V. Pickel,et al.  Localization of the δ‐opioid receptor and dopamine transporter in the nucleus accumbens shell: Implications for opiate and psychostimulant cross‐sensitization , 1999, Synapse.

[36]  R. North,et al.  Opioids excite dopamine neurons by hyperpolarization of local interneurons , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  W. Bowen,et al.  Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. , 1993, European journal of pharmacology.

[38]  D. Segal,et al.  Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.